13P Efficacy and biomarker exploration of anlotinib plus penpulimab for extensive-stage small-cell lung cancer who failed previous platinum-based chemotherapy: Results from a phase II perspective trial

Yi Zhang, Ning Yang, Qian Chen et al.|Immuno-Oncology Technology|2023

Cited by 3